Insider Transactions in Q2 2021 at Oncocyte Corp (OCX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Ronald Asbury Andrews Former CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,873
-11.76%
|
-
|
|
Jun 11
2021
|
Andrew J. Last Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
6,993
+18.82%
|
$20,979
$3.0 P/Share
|
|
May 07
2021
|
Ronald Asbury Andrews Former CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
106,221
+32.57%
|
-
|
|
Apr 28
2021
|
Mitchell S Levine Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,620
-6.93%
|
-
|
|
Apr 28
2021
|
Mitchell S Levine Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+23.07%
|
-
|